|
|
Effect of Tiotropium Bromide on bronchial asthma in the elderly |
DING Shuang |
The First Department of Respiratory Medicine,Iron and Coal General Hospital of Liaoning Health Industry Group,Liaoning Province,Tieling 112700,China |
|
|
Abstract Objective To explore the effect of Tiotropium Bromide on bronchial asthma in the elderly.Methods A total of 100 elderly patients with bronchial asthma who were admitted to Iron and Coal General Hospital of Liaoning Health Industry Group from May 2018 to January 2020 were selected as the research subjects.The patients were divided into control group and experimental group according to the random number table method,with 50 cases in each group.The control group was treated with Montelukast combined with Busulfan,while the experimental group was treated with Tiotropium Bromide based on the control group.Treatment effect,symptom disappearance time and pulmonary ventilation function index were compared between the two groups of elderly patients with bronchial asthma.Results The total effective rate of treatment in experimental group was higher than that in control group,the difference was statistically significant (P<0.05).The disappearance time of dyspnea,wheezing,cough,chest distress and other symptoms in the experimental group were shorter than those in the control group,the differences were statistically significant (P<0.05).The percentage of forced expiratory volume in the first second (FEV1%),peak respiratory flow rate (PEF),and forced vital capacity (FVC) levels in the two groups after treatment were higher than those before treatment,the differences were statistically significant (P<0.05).The FEV1%,PEF and FVC levels in the experimental group after treatment were higher than those in the control group,the differences were statistically significant (P<0.05).Conclusion Elderly patients with bronchial asthma receiving tiotropium bromide can get better results and better promote the improvement of patients′ prognosis.
|
|
|
|
|
[1] |
陈健.布地奈德、沙丁胺醇联合噻托溴铵对老年支气管哮喘血气指标、肺功能及炎症因子的影响[J].中国医药科学,2019,9(18):29-32,36.
|
[2] |
韩忠,李华,王齐,等.噻托溴铵联合布地奈德福莫特罗治疗成人重度支气管哮喘的临床观察[J].中国药房,2017,28(23):3233-3236.
|
[3] |
Trifilieff A,Ethell BT,Sykes DA,et al.Comparing the cardiovascular therapeutic indices of glycopyrronium and tiotropium in an integrated rat pharmacokinetic,pharmacodynamic and safety model[J].Toxicol Appl Pharmacol,2015,287(1):9-16.
|
[4] |
廖振辉,杨龙峰,刘国栋,等.联合噻托溴铵沙美特罗替卡松粉吸入剂治疗老年支气管哮喘的短期疗效[J].哈尔滨医药,2018,38(4):310-311.
|
[5] |
Pindelska E,Szeleszczuk L,Pisklak DM,et al.Crystal Structures of Tiotropium Bromide and Its Monohydrate in View of CombinedSolid-stateNuclearMagneticResonanceandGauge-Including Projector-Augmented Wave Studies[J].J Pharm Sci,2015,104(7):2285-2292.
|
[6] |
郭芳芳,孟洁,帖亚楠,等.噻托溴铵联合孟鲁司特治疗老年支气管哮喘的疗效及对患者肺功能的影响分析[J].医学新知杂志,2019,29(z1):48-49.
|
[7] |
宋华,佟奎鸿,王震宇,等.噻托溴铵联合沙美特罗/氟替卡松对老年支气管哮喘患者肺通气功能的疗效分析[J].中国现代药物应用,2018,12(24):97-98.
|
[8] |
王贵花.噻托溴铵辅助激素吸入治疗哮喘-慢性阻塞性肺疾病重叠综合征的肺功能改善评价[J].中国药物与临床,2019,19(20):3543-3544.
|
[9] |
曹洪芹,邓俊.噻托溴铵联合沙美特罗替卡松粉吸入剂对老年支气管哮喘的治疗效果观察[J].药品评价,2019,16(17):67-68.
|
[10] |
丁和国,王近瑜,徐玥,等.噻托溴铵粉吸入剂联合沙美特罗替卡松气雾剂对重叠综合征患者心率、肺功能及睡眠的影响[J].广东医学,2019,40(11):1644-1647,1651.
|
[11] |
叶灵燕,何苏苏,李利菊,等.噻托溴铵联合大剂量沙美特罗/氟替卡松治疗重度支气管哮喘合并COPD稳定期的临床观察[J].中国生化药物杂志,2017,37(10):130-131,133.
|
[12] |
叶娟.信必可都保联合噻托溴铵治疗对COPD 合并支气管哮喘患者肺功能、免疫功能及气道阻力的影响[J].标记免疫分析与临床,2019,26(2):264-268,289.
|
[13] |
谢刚强,唐甦,马军党,等.噻托溴铵联合大剂量沙美特罗氟替卡松治疗重度支气管哮喘合并COPD稳定期疗效研究[J].陕西医学杂志,2018,47(7):931-933,936.
|
[14] |
郭华,李松桃,陈志鸿,等.噻托溴铵联合氟伐他汀治疗重度支气管哮喘的疗效观察[J].广西医科大学学报,2019,36(2):240-243.
|
[15] |
徐杰.噻托溴铵联合大剂量舒利迭治疗重度支气管哮喘合并慢性阻塞性肺疾病的疗效[J].世界临床医学,2017,11(2):116.
|
|
|
|